Cargando…

MAGE genes: Prognostic indicators in AL amyloidosis patients

A high frequency of MAGE‐CT (cancer testis) antigens are expressed in Multiple Myeloma (MM) patients; however, in other plasma cell dyscrasias, their potential function remains unclear. We measured the expression of MAGE‐CT genes (MAGE‐C1/CT7, MAGE‐A3, MAGE‐C2/CT10) in 105 newly diagnosed amyloid li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Wen, Lei, Ma, Ling, Kang, Ying, Liu, Kai‐Yan, Huang, Xiao‐Jun, Ruan, Guo‐Rui, Lu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653474/ https://www.ncbi.nlm.nih.gov/pubmed/31222935 http://dx.doi.org/10.1111/jcmm.14475

Ejemplares similares

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer
por: Chen, Xinfeng, et al.
Publicado: (2017)

Prognostic values of novel biomarkers in patients with AL amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

P952: PROGNOSTIC SIGNIFICANCE OF DYNAMIC CHANGE OF MAGE-C1/CT7 IN MULTIPLE MYELOMA: TEN YEAR EXPERIENCE FROM A SINGLE CENTER
por: Dou, Xuelin, et al.
Publicado: (2023)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

AL Amyloidosis
por: Desport, Estelle, et al.
Publicado: (2012)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma
por: Bi, Shui-Qing, et al.
Publicado: (2022)

Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
por: Li, Wei, et al.
Publicado: (2015)

The deficiency of Maged1 attenuates Parkinson's disease progression in mice
por: Wang, Jie, et al.
Publicado: (2023)

Biomarkers in AL Amyloidosis
por: Fotiou, Despina, et al.
Publicado: (2021)

Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
por: Sapkota, Surendra, et al.
Publicado: (2022)

Correction: Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008)

Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
por: Park, Myeng-Sun, et al.
Publicado: (2002)

5-aza-2’-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells
por: Li, Zhenhua, et al.
Publicado: (2020)

Prognostic roles of MAGE family members in breast cancer based on KM-Plotter Data
por: Jia, Binghan, et al.
Publicado: (2019)

Miltiwire proportional chambers MAGE spectrometer
por: Gusev, K E, et al.
Publicado: (2003)

CRMAGE: CRISPR Optimized MAGE Recombineering
por: Ronda, Carlotta, et al.
Publicado: (2016)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

A Case of Femoral Compressive Neuropathy in AL Amyloidosis
por: Kang, Eun Ha, et al.
Publicado: (2005)

MAGE‐A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer
por: Gu, Lina, et al.
Publicado: (2018)

PB2097: CLINICAL IMPLICATION OF CYTOGENETIC ABERRATIONS IN NON-AL AMYLOIDOSIS MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE: A MULTI-CENTER CHINESE CASE SERIES
por: Liu, Yang, et al.
Publicado: (2023)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017)

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis
por: Illman, Jeffery E., et al.
Publicado: (2018)

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
por: Milani, Paolo, et al.
Publicado: (2020)

A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
por: Lu, Rebecca, et al.
Publicado: (2022)

Prognostic Factors and Survival of Chinese Patients with Cardiac Amyloidosis
por: Zhang, Lu, et al.
Publicado: (2023)

AL Amyloidosis: Unfolding a Complex Disease
por: Lu, Rebecca, et al.
Publicado: (2019)

Systemic AL Amyloidosis with Colonic Submucosal Hematoma
por: Sasaki, Sho, et al.
Publicado: (2017)

PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE
por: Liu, Yang, et al.
Publicado: (2023)

Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
por: Curioni-Fontecedro, A., et al.
Publicado: (2015)

Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis
por: Abdallah, Al-Ola, et al.
Publicado: (2012)

A Positively Selected MAGEE2 LoF Allele Is Associated with Sexual Dimorphism in Human Brain Size and Shows Similar Phenotypes in Magee2 Null Mice
por: Szpak, Michał, et al.
Publicado: (2021)

The XBabelPhish MAGE-ML and XML Translator
por: Maier, Don, et al.
Publicado: (2008)

Expression of MAGE‐1 Gene by Esophageal Carcinomas
por: Toh, Yuji, et al.
Publicado: (1995)

The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry
por: Bhargava, Rohit, et al.
Publicado: (2023)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4u47c4b6voqnrl7621ij4260s7